Relapsed Prostate Cancer: Treatments, Side Effects, & Imaging | Mark Scholz, MD | PCRI

Hormone Therapy & Side Effects For High-Risk (Gleason 8) #ProstateCancer | Mark Scholz, MD #PCRISee more

Chemo, Hormone Therapy, and Radiation For Advanced Metastatic #ProstateCancer #MarkScholzMD #PCRISee more

Focal Therapy for #ProstateCancer: Lowest Risk of ED? | #MarkScholzMD #PCRI #AlexScholzSee more

Treating Lymph Node Metastases #ProstateCancer | #MarkScholzMD | #AlexScholz #PCRISee more

2024 Moyad + Scholz Mid-Year Update | #PCRISee more

Managing Gleason 4+4=8 #prostatecancer | #markscholzmd #pcriSee more

Chemotherapy In #ProstateCancer | The PSA Response & Side Effects | #MarkScholzMD #AlexScholzSee more

2022 Recap: New Treatments and Approaches in #prostatecancer | #markscholzmd | PCRISee more

PSA After #ProstateCancer Surgery | #MarkScholzMD #AlexScholz | PCRISee more

Testosterone Replacement In #ProstateCancer Remission | #MarkScholzMD #AlexScholz #PCRISee more

A Medical Oncologist Compares Surgery and Radiation for Prostate Cancer | Mark Scholz, MD | PCRISee more

Is Seminal Vesicle Invasion Considered Metastatic Disease? | Mark Scholz, MD | PCRISee more

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4See more

MP-MRI Finding Inflammation | MRI with Hip Replacement | Mark Scholz, MD, PCRISee more

Radiation, Advanced Treatments, Side Effects, Mark Moyad, MD, MPH & Mark Scholz, MD Q+A | DAY 2See more

Radiation and Hormone Therapy | Prostate Cancer | Mark Scholz, MD | PCRISee more

Determining How Aggressively to Treat Relapsed & Intermediate-Risk Prostate Cancer | Mark Scholz, MDSee more

HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRISee more

Treatment for Few Metastases | Oligo-Metastases Disease | Mark Scholz, MD | PCRISee more

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRISee more